Skip to main content

Displaying 1 - 20 of 5024

Centerbridge Seaport Acquisition Fund/BrightSpring Health Services, Inc.

The Federal Trade Commission took action to protect Americans with intellectual and developmental disabilities and their families by requiring Sevita Health (Sevita) to divest more than 100 healthcare facilities to resolve antitrust concerns surrounding its proposed $835 million acquisition of BrightSpring Health Services, Inc.’s (BrightSpring) community living business.

Under the FTC’s proposed consent order, Sevita will be required to divest 128 intermediate care facilities (ICFs), which provide IDD services, and other assets such as day-training programs. The divested facilities—which are in Indiana, Louisiana, and Texas—will be acquired by Dungarvin Group, Inc. (Dungarvin), an experienced and well-regarded operator of ICFs.

On June 10, 2026, the FTC finalized the consent order in this matter. 

Type of Action
Federal
Last Updated
Docket Number
C-4829
Case Status
Under Order

Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)

The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.

On February 4, 2026, the Federal Trade Commission secured a landmark settlement with Express Scripts, Inc., and its affiliated entities (collectively “ESI”). The settlement requires ESI to adopt fundamental changes to its business practices that increase transparency, are expected to drive down patients’ out-of-pocket costs for drugs like insulin by up to $7 billion over 10 years, bring millions of dollars in new revenue to community pharmacies each year, and advance the Trump Administration’s key healthcare priorities.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
221 0114
Docket Number
9437
Case Status
Pending

Ascension/AMSURG, In the Matter of

The Federal Trade Commission took action to protect American patients from higher outpatient surgery costs by requiring national nonprofit health system Ascension Health Alliance (Ascension) to divest several surgery center facilities to complete its proposed $3.9 billion acquisition of AmSurg LLC.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
251 0093
Docket Number
C-4832
Case Status
Pending

Valvoline Inc./Greenbriar Equity Fund V, L.P

The Federal Trade Commission will require automotive services company Valvoline Inc. and private equity firm Greenbriar Equity Fund V., L.P. (Greenbriar) to divest 45 quick-lube oil change shops to resolve antitrust concerns surrounding their $625 million deal. Main Street Auto, LLC will acquire the divested outlets from Greenbriar under the terms of the FTC’s proposed divestiture order.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
251 0058
Docket Number
C-4824
Case Status
Pending